Explores the challenges of inferring epidemiological parameters from clinical data, focusing on COVID-19 and the complexities of estimating infection fatality ratios.
Explores preclinical and clinical trials in SMA gene therapy, including efficiency in patients, trial results, adverse effects, cellular targeting, and future perspectives.
